| To: CapitalistHogg™ who wrote (122) | 1/31/2006 1:29:15 PM | | From: CapitalistHogg™ | | | | Both MGPI and PEIX are up 50% from my cost basis.
Bush's State of the Union is going to highlight Ethanol which is why these companies have seen so much action lately.
I sold PEIX @ 18.00 but I'm already nervous about it...I want back in. |
| | Short Squeeze Stocks | Stock Discussion ForumsShare | KeepReplyMark as Last ReadRead Replies (1) |
|
| From: CapitalistHogg™ | 2/9/2006 12:37:51 PM | | | | | | Here is a list of the top short squeeze candidates. This is NOT a recommendation to buy or sell!
AVD
RVI
DV
REV
IOTN
OSIS
LTM
JEF
GHL
ESCL
FLOW
REG
CNS
CSGP
BJRI
PANL
EXP
TRN
URI
CLRK
PRST
NETL
ECLG
ZEUS
KFX
FLO
ARTC
OFC
GMT
AMG
LAB
ODSY
THO
AHS
NSTK
RNVS
RATE
RYN
AGI
AZPN
NUVA
ORB
UFPI
WTSLA
DSCO
FCH
UIC
WHR
AMT
CKH
MECA
OATS
EPIQ
BDE
HMT
USG
TIVO
LWSN
CWEI
EXEL
PSSI |
| | Short Squeeze Stocks | Stock Discussion ForumsShare | KeepReplyMark as Last Read |
|
| To: richardred who wrote (115) | 2/9/2006 12:41:40 PM | | From: CapitalistHogg™ | | | | MATK up 18% on 8-K.
8-K: MARTEK BIOSCIENCES CORP
(EDGAR Online via COMTEX) --
-------------------------------------------------------------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): February 8, 2006
Martek Biosciences Corporation __________________________________________ (Exact name of registrant as specified in its charter)
Delaware 0-22354 52-1399362 _____________________ _____________ ______________ (State or other jurisdiction (Commission (I.R.S. Employer of incorporation) File Number) Identification No.) 6480 Dobbin Road, Columbia, Maryland 21045 _________________________________ ___________ (Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: 410-740-0081
Not Applicable ______________________________________________ Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
-------------------------------------------------------------------------------- Top of the Form
Item 7.01 Regulation FD Disclosure.
Martek’s revenues for the first quarter of fiscal 2006 are expected to be between $62 and $63 million compared to previously projected first quarter revenues of $58 to $59 million. These first quarter revenues represent growth in sales to core infant formula customers.
As previously disclosed, in February 2005, we entered into a DHA license and supply agreement with a major consumer packaged goods company. There are no minimum purchase requirements or financial commitments to us under the agreement and we have not recognized any material revenues under it to date. Since entering into the agreement, Martek has been working closely with the food company on product development efforts. Based on recent discussions with the food company and progress to date on these development efforts, Martek currently believes that, while subject to final product selection, food formulation and consumer testing, the food company now projects that the initial product launch of a food containing Martek DHA will take place in 2007.
In addition, Martek expects that another major consumer packaged goods company will be announcing and making the commercial introduction of a consumer food/ beverage product containing Martek’s DHA in the first quarter of calendar 2006.
-------------------------------------------------------------------------------- Top of the Form
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Martek Biosciences Corporation February 8, 2006 By: /s/ George P. Barker ---------------------------------- Name: George P. Barker Title: Senior Vice President, General Counsel and Secretary |
| | Short Squeeze Stocks | Stock Discussion ForumsShare | KeepReplyMark as Last ReadRead Replies (1) |
|
| To: CapitalistHogg™ who wrote (127) | 2/9/2006 12:46:55 PM | | From: richardred | | | | This snip is key IMHO.
>the food company now projects that the initial product launch of a food containing Martek DHA will take place in 2007.
In addition, Martek expects that another major consumer packaged goods company will be announcing and making the commercial introduction of a consumer food/ beverage product containing Martek’s DHA in the first quarter of calendar 2006. |
| | Short Squeeze Stocks | Stock Discussion ForumsShare | KeepReplyMark as Last Read |
|
| From: CapitalistHogg™ | 2/13/2006 10:10:33 AM | | | | | | IOTN Breaking out.
IOTN is also on the Reg SHO list and has been for the last 13 trading days.
PANL $ 12.49
Universal Display Corp. -0.03
Shares Short 2,745,796
Days To Cover (Short Ratio) 16.2
Short % of Float 9.91 %
Short % Increase/Decrease 2.43 %
Price % Change (52-wk) 62.11 %
% from 52-Week HIGH ( 14.22 ) -13.85 %
% from 200 DAY MA ( 11.93 ) 4.48 %
% from 50 Day MA ( 11.95 )4.32 %
% from 52-Week LOW ( 5.77 ) 53.80 %
Shares Short -Prior Mo 2,680,555
Todays Trading Volume 7,727
Avg. Daily Volume 169,914
Volume vs. Avg 4.55 %
Market Cap 361,277,727
Outstanding Shares 28,925,359
Float 27,700,000
% Held by Insiders 9.06 %
% Held by Institutions 27.00 %
EPS -0.51
PE Ratio
Sector: Technology
Industry: Computer Peripherals |
| | Short Squeeze Stocks | Stock Discussion ForumsShare | KeepReplyMark as Last Read |
|
| |
